187 related articles for article (PubMed ID: 23617802)
1. Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection.
Zapparoli GV; Jorissen RN; Hewitt CA; McBean M; Westerman DA; Dobrovic A
BMC Cancer; 2013 Apr; 13():206. PubMed ID: 23617802
[TBL] [Abstract][Full Text] [Related]
2. [A novel modi cation of real-time AS-qPCR by using locked nucleic acid-modified oligonucleotide probe as wild type allele amplification blockers for quantitative detection of the JAK2 V617F mutation].
Shao DH; Liang GW; He ML; Cao QY
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):421-5. PubMed ID: 23688754
[TBL] [Abstract][Full Text] [Related]
3. A tetra-primer polymerase chain reaction approach for the detection of JAK2 V617F mutation.
Koksal V; Etlik O; Arican-Baris ST; Baris I
Genet Test; 2007; 11(4):463-6. PubMed ID: 18294066
[TBL] [Abstract][Full Text] [Related]
4. Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR.
Kinz E; Leiherer A; Lang AH; Drexel H; Muendlein A
Int J Lab Hematol; 2015 Apr; 37(2):217-24. PubMed ID: 24963593
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory.
Merker JD; Jones CD; Oh ST; Schrijver I; Gotlib J; Zehnder JL
J Mol Diagn; 2010 Jan; 12(1):58-64. PubMed ID: 19959796
[TBL] [Abstract][Full Text] [Related]
6. Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR.
Waterhouse M; Follo M; Pfeifer D; von Bubnoff N; Duyster J; Bertz H; Finke J
Ann Hematol; 2016 Apr; 95(5):739-44. PubMed ID: 26931113
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant Detection.
Di Francia R; Crisci S; Muto T; Giancola C; Petriccone L; Catapano O; Cummarro A; Pinto A; Frigeri F
J Appl Lab Med; 2020 Jul; 5(4):643-655. PubMed ID: 32407536
[TBL] [Abstract][Full Text] [Related]
8. A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden.
Kjær L; Westman M; Hasselbalch Riley C; Høgdall E; Weis Bjerrum O; Hasselbalch H
PLoS One; 2012; 7(3):e33100. PubMed ID: 22403733
[TBL] [Abstract][Full Text] [Related]
9. Bioluminometric assay for relative quantification of mutant allele burden: application to the oncogenic somatic point mutation JAK2 V617F.
Tsiakalou V; Petropoulou M; Ioannou PC; Christopoulos TK; Kanavakis E; Anagnostopoulos NI; Savvidou I; Traeger-Synodinos J
Anal Chem; 2009 Oct; 81(20):8596-602. PubMed ID: 19824717
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening].
Chae H; Lee JH; Lim J; Jung SW; Kim M; Kim Y; Han K; Cho BS; Cho SG; Lee JW; Min WS
Korean J Lab Med; 2009 Jun; 29(3):243-8. PubMed ID: 19571623
[TBL] [Abstract][Full Text] [Related]
11. Detection of acquired Janus kinase 2 V617F mutation in myeloproliferative disorders by fluorescence melting curve analysis.
Reading NS; Lim MS; Elenitoba-Johnson KS
Mol Diagn Ther; 2006; 10(5):311-7. PubMed ID: 17022694
[TBL] [Abstract][Full Text] [Related]
12. Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting.
Lin CY; Ho CM; Tamamyan G; Yang SF; Peng CT; Chang JG
J Clin Lab Anal; 2016 Nov; 30(6):838-844. PubMed ID: 27169616
[TBL] [Abstract][Full Text] [Related]
13. Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule fluorescence detection.
Ohyashiki K; Hori K; Makino T; Ohyashiki JH
Cancer Genet Cytogenet; 2007 Nov; 179(1):19-24. PubMed ID: 17981210
[TBL] [Abstract][Full Text] [Related]
14. A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.
Tan AY; Westerman DA; Dobrovic A
Am J Clin Pathol; 2007 Jun; 127(6):977-81. PubMed ID: 17509995
[TBL] [Abstract][Full Text] [Related]
15. Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.
Jovanovic JV; Ivey A; Vannucchi AM; Lippert E; Oppliger Leibundgut E; Cassinat B; Pallisgaard N; Maroc N; Hermouet S; Nickless G; Guglielmelli P; van der Reijden BA; Jansen JH; Alpermann T; Schnittger S; Bench A; Tobal K; Wilkins B; Cuthill K; McLornan D; Yeoman K; Akiki S; Bryon J; Jeffries S; Jones A; Percy MJ; Schwemmers S; Gruender A; Kelley TW; Reading S; Pancrazzi A; McMullin MF; Pahl HL; Cross NC; Harrison CN; Prchal JT; Chomienne C; Kiladjian JJ; Barbui T; Grimwade D
Leukemia; 2013 Oct; 27(10):2032-9. PubMed ID: 23860450
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a tetra-primer amplification refractory mutation system-polymerase chain reaction combined with melting analysis-assay for clinical JAK2 V617F mutation detection.
Liu W; Hu T; Chen Y; Zhang X; Gu X; Guan M
Mol Diagn Ther; 2014 Oct; 18(5):579-85. PubMed ID: 25015634
[TBL] [Abstract][Full Text] [Related]
17. Sensitive detection and quantification of the JAK2V617F allele by real-time PCR blocking wild-type amplification by using a peptide nucleic acid oligonucleotide.
Huijsmans CJ; Poodt J; Savelkoul PH; Hermans MH
J Mol Diagn; 2011 Sep; 13(5):558-64. PubMed ID: 21723417
[TBL] [Abstract][Full Text] [Related]
18. Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera.
Wu Z; Yuan H; Zhang X; Liu W; Xu J; Zhang W; Guan M
PLoS One; 2011; 6(10):e26534. PubMed ID: 22028900
[TBL] [Abstract][Full Text] [Related]
19. JAK2V617F allele burden in patients with myeloproliferative neoplasms.
Alshemmari SH; Rajaan R; Ameen R; Al-Drees MA; Almosailleakh MR
Ann Hematol; 2014 May; 93(5):791-6. PubMed ID: 24362471
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of a system for rapid detection of JAK2 V617F mutation in myeloproliferative diseases].
Zhang Q; Zhang Y; Xu X; Zhou W; Fan X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):980-984. PubMed ID: 31598940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
